Science and Medicine

The CABERNET Trial is an investigational study for subjects with Wet Age-Related Macular Degeneration.

The NeoVista Ophthalmic System is an investigational medical device designed to deliver a focused dose of radiation to the back of the eye (retina).

Visit the CABERNET Overview page to learn more.

NeoVista, Inc. is developing a novel therapy to treat wet Age-Related Macular Degeneration (AMD) utilizing a Strontium-90 isotope. Listed in this section are articles that will help you understand more about Wet AMD.

- Diagnosed with Age-Related Macular Degeneration

- Symptoms of Macular Degeneration

- What is Wet Macular Degeneration?

... more articles

NeoVista, Inc. is developing an intraocular epiretinal radiation device intended for the treatment of the wet form of Age-Related Macular Degeneration (AMD).

Wet AMD is the leading cause of blindness in the elderly in the US with approximately 200,000 new cases annually and a prevalence of approximately 1.5 million patients.

Visit the NeoVista, Inc. Corporate Overview page to learn more.